top
Search terms
Results 1 - 10 of 32 - ordered by :
Pages: 1 2 3 4
Epeuropace

Prevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary disease Atrial flutter cycle length and ...

Europace, Electrophysiology and ablation, Takekuni Hayashi, Seiji Fukamizu, Rintaro Hojo, Kota Komiyama, Yasuhiro Tanabe, Tamotsu Tejima, Mitsuhiro Nishizaki, Masayasu Hiraoka, Junya Ako, Shin-ichi ...

Date : 01/12/2013 Item size : 230872 bytes
Epeuropace

The latest guidelines for AF management give a class IIa (Level of Evidence A) and class IIb (Level of Evidence B) recommendation for catheter ablation of persistent and long-standing persistent ...

Europace, Editorial, Carola Gianni, Luigi Di Biase, Sanghamitra Mohanty, Andrea Natale

Date : 01/12/2015 Item size : 155046 bytes
Epeuropace

Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized ...

Europace, Ablation for atrial fibrillation, Tae-Hoon Kim, Junbeom Park, Jin-Kyu Park, Jae-Sun Uhm, Boyoung Joung, Chun Hwang, Moon-Hyoung Lee, Hui-Nam Pak

Date : 01/03/2015 Item size : 225951 bytes
Epeuropace

Abstract Aims Creation of complete linear lesions in the lateral mitral isthmus (LMI) by catheter ablation for treating atrial fibrillation remains technically challenging. Methods and results We ...

Europace, CLINICAL RESEARCH, Seiji Takatsuki, Fabrice Extramiana, Meiso Hayashi, Abdeddayem Haggui, Anne Messali, Paul Milliez, Antoine Leenhardt, Bruno Cauchemez

Date : 01/07/2009 Item size : 202021 bytes
Epeuropace

Introduction Persistent atrial fibrillation (AF) can be terminated by catheter ablation using a stepwise approach.14 The concept of this procedure is to combine pulmonary vein isolation (PVI) with ...

Europace, Ablation for atrial fibrillation, Ho-Chuen Yuen, Seung-Young Roh, Dae-In Lee, Jinhee Ahn, Dong-Hyeok Kim, Jaemin Shim, Sang-Weon Park, Young-Hoon Kim

Date : 01/09/2015 Item size : 252744 bytes
Epeuropace

Abstract Aims The mechanism of the action of flecainide in the termination of human atrial fibrillation (AF) is not fully understood. Dominant frequency (DF) and organization index (OI) were ...

Europace, CLINICAL RESEARCH, Jiun Tuan, Faizel Osman, Mohamed Jeilan, Suman Kundu, Rajkumar Mantravadi, Peter J. Stafford, G. André Ng

Date : 01/04/2010 Item size : 218444 bytes
Epeuropace

Pharmacological cardioversion preceding left atrial ablation: bepridil predicts the clinical outcome following ablation in patients with persistent atrial fibrillation Pharmacological ...

Europace, CLINICAL RESEARCH, Shinsuke Miyazaki, Taishi Kuwahara, Atsushi Kobori, Yoshihide Takahashi, Asumi Takei, Akira Sato, Mitsuaki Isobe, Atsushi Takahashi

Date : 01/12/2009 Item size : 172347 bytes
Ehjournal

Catheter ablation for AF has become a frequently used therapy that when successful can provide durable relief from symptoms and can improve AF-related co-morbities.1 AF ablation is founded upon ...

European Heart Journal, Editorial, T. Jared Bunch

Date : 07/12/2015 Item size : 174185 bytes
Epeuropace

Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease Introduction Atrial fibrillation (AF) is the most ...

Europace, Ablation for atrial fibrillation, Xiao-Yan Wu, Song-Nan Li, Song-Nan Wen, Jun-Gang Nie, Wen-Ning Deng, Rong Bai, Nian Liu, Ri-Bo Tang, Ting Zhang, Xin Du, Jian-Zeng Dong, Chang-Sheng Ma

Date : 01/10/2015
Epeuropace

Introduction Atrial tachycardias are common after repair or palliation of many types of complex congenital heart disease (CHD).1 In addition, patients with simple CHD, such as an atrial septal defect ...

Europace, CLINICAL RESEARCH, Marco Scaglione, Domenico Caponi, Elisa Ebrille, Paolo Di Donna, Francesca Di Clemente, Alberto Battaglia, Cristina Raimondo, Manuela Appendino, Fiorenzo Gaita

Date : 01/12/2014